Azithromycin Ups Sudden Cardiac Death Risk in the Hemodialysis Population
According to investigators, clinicians need to weigh the antimicrobial benefits of azithromycin, levofloxacin, and amoxicillin-based antibiotics against their potential cardiac risks in the hemodialysis population.